comparemela.com
Home
Live Updates
Innovents First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China : comparemela.com
Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
ROCKVILLE, Md. and SUZHOU, China, Feb. 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...
Related Keywords
China ,
Peking ,
Beijing ,
United States ,
Suzhou ,
Jiangsu ,
Hong Kong ,
Taiwan ,
Macau ,
Chinese ,
Innovent Biologics ,
Linong Ji ,
Adimab Incyte ,
Eli Lilly ,
Company Lilly ,
Clinical Development Of Innovent ,
Md Anderson Cancer Center ,
University People Hospital ,
National Medical Products Administration ,
Incyte Corporation ,
Linkedin ,
Institute For Health Metrics ,
Prnewswire Innovent Biologics Inc ,
Global Health Data Exchange ,
New Drug Application ,
Drug Evaluation ,
Peking University People ,
Lei Qian ,
Vice President ,
Clinical Development ,
Mainland China ,
Lancet Diabetes Endocrinol ,
Health Metrics ,
Global Health Data ,
Markets ,
comparemela.com © 2020. All Rights Reserved.